title: ISPAD Clinical Practice Consensus Guidelines 2014. Sick day management in children and adolescents with diabetes.
authors.affiliation: New England Diabetes and Endocrinology Center (NEDEC), Waltham, MA, USA.
authors.forename: Stuart
authors.initials: S
authors.lastname: Brink
authors.forename: Dipesalema
authors.initials: D
authors.lastname: Joel
authors.forename: Lori
authors.initials: L
authors.lastname: Laffel
authors.forename: Warren Wei Rhen
authors.initials: WW
authors.lastname: Lee
authors.forename: Birthe
authors.initials: B
authors.lastname: Olsen
authors.forename: Helen
authors.initials: H
authors.lastname: Phelan
authors.forename: Ragnar
authors.initials: R
authors.lastname: Hanas
mesh_terms: D000293:Adolescent; D000295:Adolescent Medicine / Q000639:trends; D002648:Child; D002675:Child, Preschool; D003131:Combined Modality Therapy / Q000009:adverse effects; D003681:Dehydration / Q000517:prevention & control; D003922:Diabetes Mellitus, Type 1 / Q000097:blood / Q000150:complications / Q000188:drug therapy / Q000628:therapy*; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000188:drug therapy / Q000628:therapy; D016883:Diabetic Ketoacidosis / Q000517:prevention & control; D016903:Drug Monitoring; D019317:Evidence-Based Medicine; D005190:Family; D006801:Humans; D006943:Hyperglycemia / Q000517:prevention & control; D007003:Hypoglycemia / Q000139:chemically induced / Q000517:prevention & control; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D007223:Infant; D007328:Insulin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D007390:International Agencies; D010353:Patient Education as Topic; D010372:Pediatrics / Q000639:trends; D057285:Precision Medicine; D012648:Self Care; D012958:Societies, Scientific
chemical_list: D007004:Hypoglycemic Agents; D007328:Insulin
keywords: DKA prevention; hydroxybutyric acid; ketones; pediatric; sick days